Morton Grove Pharmaceuticals, Inc. is recalling approximately 196,408 bottles of Prednisolone Sodium Phosphate Oral Solution (15 mg/5 mL), a prescription medication used to treat various inflammatory and allergic conditions. This recall was initiated because the product failed quality testing specifications for a specific degradation byproduct known as Prednisolone Impurity 14. These 8-ounce bottles were distributed across the United States and Puerto Rico. You should contact your doctor or pharmacist if you have this medication in your home to determine if it is part of the affected batch.
The presence of impurities or degradation products above the approved limits can potentially affect the safety, potency, and effectiveness of the medication. While no specific injuries have been reported, consuming medication that does not meet chemical specifications may result in unexpected side effects or reduced treatment efficacy.
Refund for unused medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.